Alcami Announces Manufacturing Agreement for Solasia's Active Pharmaceutical Ingredient Darinaparsin
DURHAM, North Carolina, Nov. 9, 2017 /PRNewswire/ -- Alcami, a leading provider of custom end-to-end development and manufacturing services for the pharmaceutical and biotechnology industries, today announces it has finalized manufacturing and quality agreements with Solasia Pharma, K.K. (TSE: 45...
2017-11-09 23:00
2107